AzTrials
AzTrials

Bacteremia SepsisNCT03577366

Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia

An observational study of Bacteremia Sepsis, run by Aimee Li.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Diagnostic error is an important but often under-recognized source of adverse events in the hospital. This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Bacteremia Sepsis
How many people
1,570 participants
Where
No sites listed yet
Study dates
1 Jan 2016to 13 Aug 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients included in this study will be >18 years old with a positive blood culture taken in the Emergency Department or on admission to the hospital between January 2016-August 13th,2017. No data entered into the medical chart before or after the specified dates will be collected. Among these patients, we will only review charts for those patients who did not receive treatment for sepsis on presentation by an Emergency Room physician or consultant.

Who may be able to join

  • >18 years old with a positive blood culture taken in the Emergency Department or on admission to the hospital between January 2016-August 13th,2017. No data entered into the medical chart before or after the specified dates will be collected.

Who cannot join

None listed.

About this study

Diagnostic error is an important but often under-recognized source of adverse events in the hospital. This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. The aim of this study is to determine the prevalence and characterization of diagnostic error among patients admitted to the at The Ottawa Hospital with sepsis associated with a positive blood culture. This study will consist of a retrospective chart review of all patients who are greater than 18 years with positive blood culture taken within 12 hours of presenting to the Emergency Department of Ottawa Hospital Civic and General Campus between January 2016 to August 13th 2017. For charts that are eligible for review for diagnostic errors, the qSOFA (Quick Sequential [Sepsis-related] Organ Failure Assessment) score at time at admission will be used to identify those patients who were at risk of serious harm because of a missed diagnosis of sepsis and lack of treatment. Patient variables will be collected and compared between the following three groups: (1) patients who received antibiotics within 24 hours, (2) patients who did not receive antibiotics within 24 hours and who did not meet qSOFA criteria, and (3) patients who did not receive antibiotic within 24 hours and who met qSOFA criteria. Variables to be studied include age, gender, hospital campus, admitting service, day of admission (weekend vs. weekday), time of admission (night vs. day), length of stay, disposition and Elixhauser Comorbidity Index. For charts eligible for review for diagnostic error, the DEER (Diagnostic Error Evaluation Research) Taxonomy tool will be used to classify cases per the location and type of error that occurred in the diagnostic process.

Read the detailed description

Background and Rationale:

Diagnostic error is an important but often under-recognized source of adverse events in the hospital. It ranks second as the cause of adverse events1. Studies have indicated that major diagnostic discrepancies are found in 10-20% of autopsies, and that diagnostic error is the leading cause of malpractice litigation for physicians in Canada2. Furthermore, diagnostic error is of upmost importance in the eyes of our patients: Studies have cited that 55% of patients indicated diagnostic error as their chief concern when seeing a physician. Diagnostic error occurs most commonly in areas where there is a high degree of diagnostic uncertainty such as General Internal Medicine.

Diagnostic error can be classified as either systems or cognitive errors. Systems errors involve technical failure, equipment problems and organization flaws. Systems errors have been the focus of most quality improvement and patient safety research in the past few decades. In contrast, cognitive sources of errors have received little attention despite studies indicating that the cognitive factors play in a role in up to 74% of cases involving diagnostic error. Cognitive error is defined by faulty knowledge, data gathering and synthesis of information. They often occur as the result of biases and heuristics used by physicians during the diagnostic process.

Most diagnostic errors are associated with common conditions such as sepsis, pulmonary embolism, drug intoxication, myocardial infarction and appendicitis.

This study is focused on the delayed or missed diagnosis of sepsis associated with bacteremia among patients admitted to The Ottawa Hospital. Sepsis is a common and important diagnosis. Delayed treatment is associated with significant morbidity and mortality9. Therefore, timely and correct diagnosis of sepsis is of upmost importance. No research thus far has been conducted assess the incidence and etiology of diagnostic error among patients with sepsis.

Sepsis is defined as life-threatening organ dysfunction caused by dysregulated host response to infection and the definitive diagnosis of sepsis is often complex. Given this, this study will include only patients with a missed diagnosis of sepsis who also have a positive blood cultures given the need for an objective marker of the diagnosis.

Aims and Objectives:

The aim of this study is to determine the prevalence and characterization of diagnostic error among patients admitted to the at The Ottawa Hospital with sepsis associated with a positive blood culture.

Study Design and Methods:

This study will consist of a retrospective chart review of all patients who are greater than 18 years with positive blood culture taken within 12 hours of presenting to the Emergency Department of Ottawa Hospital Civic and General Campus between January 2016 to August 13th 2017.

For patients with a positive blood culture, charts will be reviewed only for those patients who did not receive treatment for sepsis on presentation by an Emergency Room (ER) physician or consultant within the first 24 hours.

Patients with positive blood cultures with an organism that is deemed a probable-contaminant organism from the study will be excluded. For this study, probable contaminant organisms will be defined as the following: (1) Coagulase-negative staphylococci (CoNs), (2) Bacillus species other than Bacillus anthracis, (3) Propionbacterium acnes and (4) Corynebacterium species. Coagulase negative staphylocci (CoNs) will be considered as a probable-contaminant if detected in only one bottle or the minority of bottles within a blood culture set in the absence of risk factors for invasive infection. Risk factors for CoNs invasive infection include intravascular catheters, hemodialysis catheters, vascular grafts, recent prosthetic joints or hardware, presence of pacemaker or prosthetic cardiac valves. Bacillus species, Proprionbacterium acnes and Corynebacterium species, will be considered contaminants if they are detected in one or the minority of bottles in a blood culture set.

For charts that are eligible for review for diagnostic errors, the qSOFA (Quick Sequential [Sepsis-related] Organ Failure Assessment) score at time at admission will be used to identify those patients who were at risk of serious harm because of a missed diagnosis of sepsis and lack of treatment. The qSOFA is a score included in the Sepsis-3 Recommendations published in 2016, and is a validated bedside tool used for out-of-hospital, emergency department or general hospital ward settings in which patients with a suspected infection can be rapidly identified as being more likely to have poor outcomes typical of sepsis. The score consists of the following criteria and a score of 2 or more criteria correlates to worse outcomes: (1) respiratory rate of 22/min or greater, (2) altered mentation and (3) systolic blood pressure of 100mm Hg or less.

Patient variables will be collected and compared between the following three groups: (1) patients who received antibiotics within 24 hours, (2) patients who did not receive antibiotics within 24 hours and who did not meet qSOFA criteria, and (3) patients who did not receive antibiotic within 24 hours and who met qSOFA criteria. Variables to be studied include age, gender, hospital campus, admitting service, day of admission (weekend vs. weekday), bacteria species, time of admission (night vs. day), length of stay, disposition and Elixhauser Comorbidity Index.

For charts eligible for review for diagnostic error, the DEER (Diagnostic Error Evaluation Research) Taxonomy tool will be used to classify cases per the location and type of error that occurred in the diagnostic process.

Keywords
Bacteremia, Sepsis, Diagnostic Error
Medical subject headings
Bacteremia, Sepsis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic Error

    Prevalence and Characterization of Diagnostic Error

    Measured: January 2016-August 13th, 2017

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2018
  2. Study start1 Jan 2016
  3. Primary completion13 Aug 2017
  4. Study completion13 Aug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
1,570 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03577366
Sponsor's protocol ID
7099
Status last verified
Jul 2018
First submitted
24 Jun 2018
Last updated
6 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bacteremia Sepsis, run by Aimee Li.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic Error (time frame: January 2016-August 13th, 2017). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in